Phyto Chem (India) Ltd

Phyto Chem (I) has shown a declining trend in net sales and profitability, with net sales dropping from 44.49 Cr in Mar'21 to 14.08 Cr in Mar'25, resulting in significant losses and negative operating profit. The company's financial health has deteriorated, reflected in increasing losses and stagnant cash flow.

On 21-Nov, Phyto Chem (India) Ltd witnessed a significant rise in its share price, climbing 7.64% to close at ₹31.85. This notable uptick reflects a strong short-term momentum that has outpaced both its sector and broader market benchmarks.

As of 18-Nov, Phyto Chem (India) Ltd's stock price is at 28.49, showing a slight increase today but a negative year-to-date performance of -17.30%. Despite a recent trend reversal and increased delivery volume, the stock continues to underperform against the benchmark Sensex over various periods.

Phyto Chem (I) has experienced a significant decline in net sales and profitability, with net sales dropping from 44.49 Cr in Mar'21 to 14.08 Cr in Mar'25, resulting in negative profits in the latest fiscal year. Total liabilities and assets also decreased, while cash flow from operating activities remained stagnant.

Phyto Chem (I) has shown a declining trend in net sales and profitability, with net sales dropping from 44.49 Cr in March 2021 to 14.08 Cr in March 2025, and reporting significant losses in recent years, including a profit after tax loss of 0.99 Cr in March 2025. Total liabilities and assets have also decreased, indicating a challenging financial environment.

As of 10-Nov, Phyto Chem (India) Ltd's stock price is Rs 28.61, down 6.17%, with significant volatility and underperformance compared to its sector. The company's weak fundamentals and negative returns indicate it is a strong sell in the current market.

Phyto Chem (I) will announce its results on 14 November 2025.

As of 07-Nov, Phyto Chem (India) Ltd is currently priced at Rs 30.49, reflecting a 7.89% increase. The stock has outperformed its sector and shows strong upward momentum, trading above key moving averages, despite a year-to-date decline.

As of 04-Nov, Phyto Chem (India) Ltd's stock price has risen to Rs 29.75, up 8.7%, outperforming its sector today. Despite recent gains, the stock is down 13.64% year-to-date, indicating long-term struggles despite short-term positive performance.

As of 30-Oct, Phyto Chem (India) Ltd's stock price is Rs 26.63, down 6.23%, and has underperformed its sector and the broader market significantly. The stock has declined 28.03% over the past year, with no current catalysts influencing its ongoing decline.

As of 29-Oct, Phyto Chem (India) Ltd is currently priced at Rs 27.90, reflecting a recent increase but a year-to-date decline of 19.01%. Despite outperforming the sector in the short term, declining investor participation raises concerns about future interest in the stock.

As of 26-Sep, Phyto Chem (India) Ltd's stock price is declining at 26.50, down 1.92%, and has lost 5.02% over the last three days. The stock is underperforming compared to the broader market and has seen a significant drop in investor participation.

As of 23-Sep, Phyto Chem (India) Ltd is priced at 27.90, showing a short-term gain but facing significant financial challenges, including operating losses and a high Debt to EBITDA ratio. Despite recent positive performance, the stock has underperformed over the longer term, raising investor caution due to declining net sales and profitability.

As of 19-Sep, Phyto Chem (India) Ltd's stock price is at 27.87, down 0.11%, and has underperformed its sector. Despite a short-term gain of 2.09% over the past week, it has a year-to-date decline of 19.10%, indicating a negative overall trajectory compared to the market.

As of 18-Sep, Phyto Chem (India) Ltd is seeing a price increase to 27.90, up 2.95%, but it remains down 19.01% year-to-date. Despite today's rise, the stock lags behind the Sensex's 6.24% gain, indicating ongoing challenges.

As of 09-Sep, Phyto Chem (India) Ltd is currently priced at 28.50, reflecting a 2.52% increase and outperforming the Sensex in the short term. Despite a year-to-date decline of 17.27%, the stock shows strong short-term momentum with rising investor participation.